🇺🇸 FDA
Pipeline program

PEG-somatropin

GenSci 004 CT-2

Approved mab active

Quick answer

PEG-somatropin for Growth Hormone Deficiency is a Approved program (mab) at Changchun GeneScience Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Changchun GeneScience Pharmaceutical Co.,
Indication
Growth Hormone Deficiency
Phase
Approved
Modality
mab
Status
active

Clinical trials